2017
DOI: 10.1080/13510002.2017.1418620
|View full text |Cite
|
Sign up to set email alerts
|

Redox status of patients before cardiac surgery

Abstract: A: absorption; ΔA: absorption difference; ABTS: 2,2'-azino-di(3-ethylbenzothiazoline sulfonate); ACE: angiotensin-converting enzyme; AO: antioxidant; ARB: angiotensin receptor blocker; BMI: body mass index; CAD: coronary artery disease; CCB: calcium channel blocker; CDC: coronary heart diseases; COPD: chronic obstructive pulmonary disease; CRP: C-reactive protein; CVD: cardiovascular diseases; Cu-OOH: cumene hydroperoxide; D: dilution factor; DAN: 2,3-diaminonaphtalene; DMSO: dimethylsulfoxide; DNA: deoxyribon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 56 publications
1
4
0
Order By: Relevance
“…In humans, this correlation was related to the serum content of uric acid, one of the major components determining the antioxidant status in human serum (Erel, 2004;Jansen and Ruskovska, 2013), as previously in vitro observed by Benzie and Strain (1996) and Re et al (1999). The lack of correlation between TAC and TAA in our data could be explained by the lower uric acid content in goat compared to humans (Silanikove et al, 1996). Thus, the assessed antioxidant assays were less influenced by the uric acid contribution, which represents 60 % of the antioxidant capacity measured by FRAP assay in human samples (Cao and Prior, 1998).…”
Section: Discussionsupporting
confidence: 82%
“…In humans, this correlation was related to the serum content of uric acid, one of the major components determining the antioxidant status in human serum (Erel, 2004;Jansen and Ruskovska, 2013), as previously in vitro observed by Benzie and Strain (1996) and Re et al (1999). The lack of correlation between TAC and TAA in our data could be explained by the lower uric acid content in goat compared to humans (Silanikove et al, 1996). Thus, the assessed antioxidant assays were less influenced by the uric acid contribution, which represents 60 % of the antioxidant capacity measured by FRAP assay in human samples (Cao and Prior, 1998).…”
Section: Discussionsupporting
confidence: 82%
“…Extensive increase in ROS levels results in oxidative stress. Correspondingly, monitoring the redox status of patients before and after cardiovascular surgical procedures by determining redox parameters, i.e., total antioxidant status, total glutathione concentrations, glutathione peroxidase activity, and both nitrite and nitrate concentrations in the peripheral blood of patients, can be of great impact (Schuh et al, 2018) for optimal treatment in the postoperative time period. In future clinical studies, when PS is used, a combination of mitochondria-specific antioxidants or ROS scavengers to reverse the side effect of PS should be evaluated.…”
Section: Discussionmentioning
confidence: 99%
“…It is likely that prolonged administration of OT in CAD patients with elevated basal angiotensin-II levels accelerated angiotensin-II-induced hypertension and renal damage (Gu et al, 2016). Since elevated basal levels of angiotensin-II is common among patients with CAD complications (Schuh et al, 2017), alternative approaches of OT application should be considered.…”
Section: Limitation For Therapeutic Use Of Otmentioning
confidence: 99%